In our study, the baseline proportion of both IL-17A- and IFN-γ-producing PBMCs were significantly higher in HCV-infected patients than in the healthy controls, indicating that activation of Th17 cells may be involved in development of the HCV induced liver diseases by releasing pro-inflammatory cytokines. Here, IL17A is linked to liver disorder.